PRESS RELEASE published on 03/13/2025 at 14:01, 1 year 8 months ago Healthcare Specialist SHS Capital, together with its co-investors, sells Selfapy GmbH to MEDICE - The Health Family SHS Capital and co-investors sell Selfapy GmbH to MEDICE - The Health Family, a step towards clinically validated healthcare solutions integrating pharmaceuticals and digital concepts Healthcare Solutions Digital Health SHS Capital Selfapy GmbH MEDICE
PRESS RELEASE published on 03/13/2025 at 14:00, 1 year 8 months ago Vox Royalty Provides Development Updates and Approval of 2025 Share Repurchase Program Vox Royalty Corp. provides updates on mining royalty partners Black Cat Syndicate Limited, Orla Mining Ltd., and Galway Metals Inc. Recent developments include new acquisitions and progress towards production in Western Australia, Nevada, and Quebec Acquisitions Vox Royalty Corp. Production Mining Royalty Partners
PRESS RELEASE published on 03/13/2025 at 13:45, 1 year 8 months ago bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne bonyf secures EU Patent, pending US patent, for PerioTabs® & PerioCream, set to launch at IDS Cologne in March 2025. Products aim to revolutionize dental care practices globally Bonyf PerioTabs EU Patent PerioCream IDS Cologne
PRESS RELEASE published on 03/13/2025 at 13:41, 1 year 8 months ago Form 8.3 - Equals Group PLC Chelverton Asset Management discloses a 1.18% stake in Equals Group PLC. No other disclosures made Stake Chelverton Asset Management Equals Group PLC Disclosures 1.18%
PRESS RELEASE published on 03/13/2025 at 13:38, 1 year 8 months ago REPLY: The Board of Directors approved the draft financial statements for the year 2024 Reply S.p.A. Board of Directors approves draft financial statements for 2024, proposing dividend distribution of €1.15 per share. Positive financial indicators with increased turnover and net profit Board Of Directors Financial Statements Dividend Distribution Reply S.p.A. Positive Indicators
PRESS RELEASE published on 03/13/2025 at 13:30, 1 year 8 months ago Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses Xenetic Biosciences presents promising findings on combining DNase I with CAR T cells to enhance cancer treatment strategies at the SITC Spring Scientific 2025 Cell Therapy Meeting Xenetic Biosciences Cancer Treatment DNase I CAR T Cells SITC Spring Meeting
PRESS RELEASE published on 03/13/2025 at 13:30, 1 year 8 months ago Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform Aspire Biopharma Holdings, Inc. provides update on patent applications for Oral Mucosal Formulations of Aspirin with rapid absorption technology. Company aims to revolutionize drug delivery and improve patient outcomes Drug Delivery Technology Patent Applications Aspire Biopharma Oral Mucosal Formulations Aspirin
PRESS RELEASE published on 03/13/2025 at 13:18, 1 year 8 months ago Inside Information / Other news releases French Competition Authority approves Carmila's acquisition of Galimmo, Carmila to sell Villers Semeuse shopping gallery in 2025. No significant impact on financial targets Acquisition Competition Authority CARMILA Galimmo Villers Semeuse
PRESS RELEASE published on 03/13/2025 at 13:00, 1 year 8 months ago Prince Holding Group Earns Fifth Consecutive ‘Best in Cambodia’ Award for CSR Initiatives Prince Holding Group recognized as 'Best in Country Excellence - Best in Cambodia' at the 17th Annual Global CSR & ESG Awards for sustainable development efforts. Awards highlight ongoing CSR and ESG initiatives guided by Chairman Chen Zhi Sustainable Development Prince Holding Group Chen Zhi CSR Initiatives Global CSR Awards
PRESS RELEASE published on 03/13/2025 at 13:00, 1 year 8 months ago MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain MIRA Pharmaceuticals introduces topical Ketamir-2 for neuropathic and inflammatory pain, expanding pain management portfolio with innovative targeted approach MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain Topical Treatment Inflammatory Pain
Published on 11/20/2026 at 15:00, 1 day 3 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 1 day 3 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 day 4 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 day 4 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 day 4 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 18 hours 43 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 21:36, 20 hours 52 minutes ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 19:26, 23 hours 3 minutes ago EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack
Published on 11/20/2026 at 19:03, 23 hours 25 minutes ago EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group
Published on 11/20/2026 at 18:34, 23 hours 54 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 1 day 23 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 08:30, 2 days 9 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing